Page last updated: 2024-11-12

feaox-6

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

FeAOX-6: antioxidant derived from a molecular combination of the chromanyl and polyisoprenyl moieties; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID16664359
MeSH IDM0459570

Synonyms (8)

Synonym
uu87wo570z ,
2h-1-benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-((3e,5e,7e)-4,8,12-trimethyl-1,3,5,7,11-tridecapentaenyl)-
2h-1-benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-((3e,5e,7e)-4,8,12-trimethyl-1,3,5,7,11-tridecapentaen-1-yl)-
unii-uu87wo570z
feaox-6
545399-88-0
Q27291280
2,5,7,8-tetramethyl-2-[(1e,3e,5e,7e)-4,8,12-trimethyltrideca-1,3,5,7,11-pentaenyl]-3,4-dihydrochromen-6-ol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]